| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 110.4 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Biomarkers from interstitial skin fluid (ISF) complement conventional biofluids for point-of-care testing and real-time monitoring. In this study, we propose a new approach that combines microneedle technology with molecularly imprinted polymers to improve transdermal electrochemical sensing. The molecularly imprinted polymer, which acts like a plastic antibody, is easy to synthesis and scalable, offering a low detection limit and rapid measurement (20 minutes). It detects IL -6, a proinflammatory cytokine associated with several clinical conditions, including neurological disease and pneumonia caused by SARS-CoV-2. The transdermal sensors successfully identified IL -6 in simulated skin ISF at very low concentrations (1 pg/mL). This breakthrough
enables affordable and bloodless testing, facilitating access to point-of-care testing worldwide. The integration of molecularly imprinted polymers and microneedle arrays is very promising for efficient transdermal electrochemical sensing that could find application in various clinical scenarios.
Descrição
Palavras-chave
Microneedles; Interstitial skin fluid; Electrochemistry; Biosensor
Contexto Educativo
Citação
Oliveira, D., Correia, B.P., Sharma, S., & Moreira, F.T.C. (2023, September 11-15). Transdermal electrochemical sensing: Combining microneedles with molecularly imprinted polymers for point-of-care testing [Conference session]. NanoBio 2023 - 2nd International Conference on Nanotechnologies and Bionanoscience, Heraklion, Crete, Greece